BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pearson MS, Becker L, Driguez P, Young ND, Gaze S, Mendes T, Li XH, Doolan DL, Midzi N, Mduluza T, McManus DP, Wilson RA, Bethony JM, Nausch N, Mutapi F, Felgner PL, Loukas A. Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates. Front Immunol 2015;6:213. [PMID: 25999951 DOI: 10.3389/fimmu.2015.00213] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Molehin AJ, McManus DP, You H. Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects. Int J Mol Sci 2022;23:2255. [PMID: 35216369 DOI: 10.3390/ijms23042255] [Reference Citation Analysis]
2 Panzner U, Excler J, Kim JH, Marks F, Carter D, Siddiqui AA. Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis. Front Trop Dis 2021;2:719369. [DOI: 10.3389/fitd.2021.719369] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 McManus DP. The Search for a Schistosomiasis Vaccine: Australia's Contribution. Vaccines (Basel) 2021;9:872. [PMID: 34451997 DOI: 10.3390/vaccines9080872] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 You H, Mayer JU, Johnston RL, Sivakumaran H, Ranasinghe S, Rivera V, Kondrashova O, Koufariotis LT, Du X, Driguez P, French JD, Waddell N, Duke MG, Ittiprasert W, Mann VH, Brindley PJ, Jones MK, McManus DP. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase. FASEB J 2021;35:e21205. [PMID: 33337558 DOI: 10.1096/fj.202001745RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
5 Pearson MS, Tedla BA, Becker L, Nakajima R, Jasinskas A, Mduluza T, Mutapi F, Oeuvray C, Greco B, Sotillo J, Felgner PL, Loukas A. Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis. Front Immunol 2021;12:663041. [PMID: 34113343 DOI: 10.3389/fimmu.2021.663041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Al-Naseri A, Al-Absi S, El Ridi R, Mahana N. A comprehensive and critical overview of schistosomiasis vaccine candidates. J Parasit Dis 2021;:1-24. [PMID: 33935395 DOI: 10.1007/s12639-021-01387-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 McCusker P, Rohr CM, Chan JD. Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure. PLoS Negl Trop Dis 2021;15:e0009200. [PMID: 33657133 DOI: 10.1371/journal.pntd.0009200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu HW, Park S, Pond-Tor S, Stuart R, Zhou S, Hong Y, Ruiz AE, Acosta L, Jarilla B, Friedman JF, Jiz M, Kurtis JD. Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica. J Infect Dis 2021;223:1265-74. [PMID: 33606021 DOI: 10.1093/infdis/jiab085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Tedla BA, Pickering D, Becker L, Loukas A, Pearson MS. Vaccination with Schistosoma mansoni Cholinesterases Reduces the Parasite Burden and Egg Viability in a Mouse Model of Schistosomiasis. Vaccines (Basel) 2020;8:E162. [PMID: 32260125 DOI: 10.3390/vaccines8020162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Li XH, Vance GM, Cartwright J, Cao JP, Wilson RA, Castro-Borges W. Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs. PLoS One 2020;15:e0229542. [PMID: 32107503 DOI: 10.1371/journal.pone.0229542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. Schistosomiasis-from immunopathology to vaccines. Semin Immunopathol 2020;42:355-71. [PMID: 32076812 DOI: 10.1007/s00281-020-00789-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
12 Ma L, Zhao W, Hou X, Liu M, Li Y, Shen L, Xu X. Identification of linear epitopes in SjSP-13 of Schistosoma japonicum using a GST-peptide fusion protein microplate array. Parasit Vectors 2019;12:507. [PMID: 31666115 DOI: 10.1186/s13071-019-3767-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hotez PJ, Bottazzi ME, Bethony J, Diemert DD. Advancing the Development of a Human Schistosomiasis Vaccine. Trends Parasitol 2019;35:104-8. [PMID: 30455112 DOI: 10.1016/j.pt.2018.10.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
14 You H, Liu C, Du X, Nawaratna S, Rivera V, Harvie M, Jones M, McManus DP. Suppression of Schistosoma japonicum Acetylcholinesterase Affects Parasite Growth and Development. Int J Mol Sci 2018;19:E2426. [PMID: 30115897 DOI: 10.3390/ijms19082426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
15 Leontovyč A, Ulrychová L, O'Donoghue AJ, Vondrášek J, Marešová L, Hubálek M, Fajtová P, Chanová M, Jiang Z, Craik CS, Caffrey CR, Mareš M, Dvořák J, Horn M. SmSP2: A serine protease secreted by the blood fluke pathogen Schistosoma mansoni with anti-hemostatic properties. PLoS Negl Trop Dis 2018;12:e0006446. [PMID: 29677188 DOI: 10.1371/journal.pntd.0006446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
16 Shears RK, Bancroft AJ, Sharpe C, Grencis RK, Thornton DJ. Vaccination Against Whipworm: Identification of Potential Immunogenic Proteins in Trichuris muris Excretory/Secretory Material. Sci Rep 2018;8:4508. [PMID: 29540816 DOI: 10.1038/s41598-018-22783-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
17 Dvorak J, Horn M. Serine proteases in schistosomes and other trematodes. Int J Parasitol 2018;48:333-44. [PMID: 29477711 DOI: 10.1016/j.ijpara.2018.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Wilson RA, Li XH, Castro-Borges W. Schistosome vaccines: problems, pitfalls and prospects. Emerg Top Life Sci 2017;1:641-50. [PMID: 33525844 DOI: 10.1042/ETLS20170094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 You H, Liu C, Du X, McManus DP. Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths. Molecules 2017;22:E1550. [PMID: 28906438 DOI: 10.3390/molecules22091550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Sotillo J, Toledo R, Mulvenna J, Loukas A. Exploiting Helminth-Host Interactomes through Big Data. Trends Parasitol 2017;33:875-88. [PMID: 28734897 DOI: 10.1016/j.pt.2017.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
21 Cameron TC, Cooke I, Faou P, Toet H, Piedrafita D, Young N, Rathinasamy V, Beddoe T, Anderson G, Dempster R, Spithill TW. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep. Int J Parasitol 2017;47:555-67. [PMID: 28455238 DOI: 10.1016/j.ijpara.2017.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
22 Yang YY, Li XH, Brzezicka K, Reichardt NC, Wilson RA, van Diepen A, Hokke CH. Specific anti-glycan antibodies are sustained during and after parasite clearance in Schistosoma japonicum-infected rhesus macaques. PLoS Negl Trop Dis 2017;11:e0005339. [PMID: 28151933 DOI: 10.1371/journal.pntd.0005339] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
23 Sotillo J, Doolan D, Loukas A. Recent advances in proteomic applications for schistosomiasis research: potential clinical impact. Expert Review of Proteomics 2017;14:171-83. [DOI: 10.1080/14789450.2017.1271327] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kassegne K, Abe EM, Chen J, Zhou X. Immunomic approaches for antigen discovery of human parasites. Expert Review of Proteomics 2016;13:1091-101. [DOI: 10.1080/14789450.2016.1252675] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
25 Tebeje BM, Harvie M, You H, Loukas A, McManus DP. Schistosomiasis vaccines: where do we stand? Parasit Vectors 2016;9:528. [PMID: 27716365 DOI: 10.1186/s13071-016-1799-4] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 15.7] [Reference Citation Analysis]
26 You H, Gobert GN, Du X, Pali G, Cai P, Jones MK, McManus DP. Functional characterisation of Schistosoma japonicum acetylcholinesterase. Parasit Vectors 2016;9:328. [PMID: 27283196 DOI: 10.1186/s13071-016-1615-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
27 Hotez PJ, Strych U, Lustigman S, Bottazzi ME. Human anthelminthic vaccines: Rationale and challenges. Vaccine 2016;34:3549-55. [DOI: 10.1016/j.vaccine.2016.03.112] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
28 de Assis RR, Ludolf F, Nakajima R, Jasinskas A, Oliveira GC, Felgner PL, Gaze ST, Loukas A, LoVerde PT, Bethony JM, Correa-Oliveira R, Calzavara-Silva CE. A next-generation proteome array for Schistosoma mansoni. Int J Parasitol 2016;46:411-5. [PMID: 27131510 DOI: 10.1016/j.ijpara.2016.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
29 Merrifield M, Hotez PJ, Beaumier CM, Gillespie P, Strych U, Hayward T, Bottazzi ME. Advancing a vaccine to prevent human schistosomiasis. Vaccine 2016;34:2988-91. [PMID: 27036511 DOI: 10.1016/j.vaccine.2016.03.079] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 11.3] [Reference Citation Analysis]
30 Driguez P, McManus DP, Gobert GN. Clinical implications of recent findings in schistosome proteomics. Expert Rev Proteomics 2016;13:19-33. [PMID: 26558506 DOI: 10.1586/14789450.2016.1116390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
31 El Ridi R, Othman AA, McManus DP. Editorial: The Schistosomiasis Vaccine - It is Time to Stand up. Front Immunol 2015;6:390. [PMID: 26284073 DOI: 10.3389/fimmu.2015.00390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li XH, Xu YX, Vance G, Wang Y, Lv LB, van Dam GJ, Cao JP, Wilson RA. Evidence That Rhesus Macaques Self-Cure from a Schistosoma japonicum Infection by Disrupting Worm Esophageal Function: A New Route to an Effective Vaccine? PLoS Negl Trop Dis 2015;9:e0003925. [PMID: 26161644 DOI: 10.1371/journal.pntd.0003925] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]